No Data
Unusual Options Activity: IBN, BE and Others Attract Market Bets, IBN V/OI Ratio Reaches 312.5
EST Jul 20th Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
What Comes After Merck's Keytruda? The Race for the Next Standard Cancer Treatment. -- Barrons.com
Mega-mergers, policy shifts, and a data surge... On the eve of a transformation in the psychedelics sector, the market received a bullish signal worth $3.8 billion.
Last Thursday, Eli Lilly and Co announced it would acquire AtaiBeckley, a clinical-stage psychedelic drug developer, for up to $3.8 billion. This move signals that large pharmaceutical companies are increasingly embracing these long-stigmatized substances as alternative treatments for a range of mental health disorders.
Notable Healthcare Headlines for the Week: UnitedHealth, J&J, and Intuitive Surgical in Focus
Earnings Scoreboard: 100% of S&P 500 Early Reporters Beat EPS Estimates as Y/Y Growth Hits 26 Firms
Meta's Latest Move in the AI Talent War — Plus Cramer's 4 Quick Hits on the Market